한글목차

세계 경카테터 판막 수복 시스템 시장의 장래성은 병원, 전문 클리닉, 외래 수술 센터 시장에서의 기회로 인해 유망합니다. 경카테터 판막 수복 시스템 세계 시장은 2025년부터 2031년까지 CAGR 7.7%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 심장 질환의 유병률 증가, 판막 질환에 대한 덜 침습적인 시술에 대한 환자 선호도 증가, 경카테터 판막 복원 기술의 지속적인 발전입니다.

• 제품 유형별로는 경카테터 대동맥판 치환술이 가장 높은 성장세를 보일 것으로 Lucintel은 예측했습니다.
• 최종 용도별로는 병원이 가장 높은 성장이 예상됩니다.
• 지역별로는 북미가 헬스케어 인프라가 잘 구축되어 있어 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

경카테터 판막 수복 시스템 시장의 전략적 성장 기회

경카테터 판막 수복 시스템 시장에는 주요 응용 분야에 걸쳐 수많은 전략적 성장 기회가 있습니다. 이러한 분야에 집중함으로써 이해관계자들은 시장에서의 입지를 강화하고 환자 치료를 개선할 수 있습니다.

• 노인 의료의 확대 : 고령화 인구의 증가는 기존 수술로 높은 위험에 직면하는 노인 환자들을 위한 경카테터 솔루션의 개발 기회를 제공합니다.
• 맞춤형 디바이스 개발 : 개인별 해부학적 변화에 대응하는 맞춤형 경카테터 디바이스를 개발함으로써 시술 성공률을 높이고 환자의 예후를 개선할 수 있습니다.
• 원격의료와의 통합 증가 : 수술 전후 치료에 원격의료 솔루션을 통합하여 환자 관리를 간소화하고, 특히 지방에서 전문의에 대한 접근성을 향상시킬 수 있습니다.
• 임상시험의 중요성 : 경카테터 판막 복원 시스템의 새로운 용도에 대한 임상시험에 투자함으로써 규제 당국의 승인을 지원하고 시장 수용성을 높일 수 있는 귀중한 데이터를 확보할 수 있습니다.

이러한 전략적 성장 기회는 제품 제공 강화, 환자 접근성 개선, 기술 혁신 촉진으로 경카테터 판막 수복 시스템 시장을 형성하고 있습니다. 이러한 기회를 활용하는 이해관계자는 변화하는 헬스케어 환경에서 경쟁력을 강화할 수 있습니다.

경카테터 판막 수복 시스템 시장 촉진요인 및 과제

경카테터 판막 수복 시스템 시장은 기술, 경제, 정책의 역동성과 상호 작용하고 있으며, 이는 촉진 및 억제요인으로 작용하고 있습니다. 이러한 요인에 대한 지식은 빠르게 변화하는 이 시스템에 참여하고자 하는 이해관계자들에게 중요합니다.

경카테터 판막증 치료 시스템 시장을 견인하는 요인은 다음과 같습니다:

1. 심장병 발생률 증가 : 심장병 발생률이 지속적으로 증가함에 따라 카테터를 이용한 새로운 시술에 대한 수요가 증가하고 있으며, 이는 시장 성장의 여지를 충분히 제공하고 있습니다.

2. 기술 발전 : 장치 구조 및 장치 재료를 포함한 장치 기술의 개선은 경카테터 밸브 치료에 혁명을 일으키고 임상의를 더욱 끌어 들이고 있습니다.

3. 최소침습적 치료에 대한 환자 선호도 : 환자의 지식과 최소침습적 시술에 대한 요구 수준이 높아지면서 경카테터 판막 복원 시스템 시장에 긍정적인 영향을 미치고 있습니다.

4. 우호적인 규제 환경 : 일부 국가에서는 규제 당국의 우호적인 정책으로 인해 시장 내 신규 기기 승인에 소요되는 시간이 단축되어 새로운 아이디어를 촉진하고 이 분야에서의 경쟁을 강화하는 데 도움이 되고 있습니다.

5. 심혈관 연구에 대한 투자 증가 : 심혈관 연구에 더 많은 자금이 투입되면 현재 수요가 있고 표준 치료를 개선하는 새로운 경카테터 치료법의 개발이 촉진될 것입니다.

경카테터 판막 수복 시스템 시장의 과제는 다음과 같습니다:

1. 높은 시술 비용 : 경카테터 치료가 가능해지면 그에 따른 고비용이 발생하여 일부 환자는 치료를 받지 못할 수 있습니다.

2. 규제 장애물 : 현재의 규제는 긍정적인 요소도 있지만, 새로운 장비, 특히 신제품 개발에 대한 승인은 복잡할 수 있으며, 신제품의 시장 출시를 지연시키는 원인이 될 수 있습니다.

3. 기존 수술 방법의 위협 : 기존의 전통적인 치료법은 여전히 많은 수의 전통적인 치료법이 존재하며, 이는 경카테터 솔루션에 대한 도전이며, 그 유용성을 지속적으로 입증해야 합니다.

경카테터 판막증 치료 시스템 시장에서는 이러한 시장 촉진요인 및 이슈의 관계가 중요합니다. 이러한 외교적 관계가 있다면 이해관계자들은 더 나은 제품을 만들고, 양질의 환자 치료를 제공할 수 있으며, 치료 방법을 더 나은 방향으로 변화시키는 데 도움이 될 것으로 보입니다.

목차

제1장 주요 요약

제2장 세계의 경카테터 판막 수복 시스템 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2019년부터 2031년까지 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 경카테터 판막 수복 시스템 시장 동향(2019-2024년)과 예측(2025-2031년)
• 제품 유형별, 경카테터 판막 수복 시스템 세계 시장
  • 경카테터 대동맥판 치환술
  • 경카테터 승모판 치환술
  • 경카테터 폐동맥판 치환술
  • 경카테터 삼첨판 치환술
• 용도별, 경카테터 판막 수복 시스템 세계 시장
  • 대동맥판협착증
  • 승모판협착증
  • 삼첨판협착증
  • 폐동맥협착증
• 최종 용도별, 경카테터 판막 수복 시스템 세계 시장
  • 병원
  • 전문 클리닉
  • 외래 수술 센터
  • 기타

제4장 2019년부터 2031년까지 지역별 시장 동향과 예측 분석

• 지역별 경카테터 판막 수복 시스템 세계 시장
• 북미의 경카테터 판막 수복 시스템 시장
• 유럽의 경카테터 판막 수복 시스템 시장
• 아시아태평양의 경카테터 판막 수복 시스템 시장
• 기타 지역의 경카테터 판막 수복 시스템 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 경카테터 판막 수복 시스템 시장 성장 기회, 제품 유형별
  • 세계의 경카테터 판막 수복 시스템 시장 성장 기회, 용도별
  • 세계의 경카테터 판막 수복 시스템 시장 성장 기회, 최종 용도별
  • 세계의 경카테터 판막 수복 시스템 시장 성장 기회, 지역별
• 세계의 경카테터 판막 수복 시스템 시장의 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 경카테터 판막 수복 시스템 시장 능력 확대
  • 세계의 경카테터 판막 수복 시스템 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Abbott Laboratories
• Medtronic
• Boston Scientific
• Edwards Lifesciences
• Bracco Group
• LivaNova
• Meril Life Sciences
• Sorin Group
• Cordis
• MicroPort Scientific

영문목차

The future of the global transcatheter valve repair system market looks promising with opportunities in the hospital, specialty clinic, and ambulatory surgical center markets. The global transcatheter valve repair system market is expected to grow with a CAGR of 7.7% from 2025 to 2031. The major drivers for this market are the rise in the prevalence of cardiac conditions, increasing patient preferences for less invasive procedures for valve diseases, and ongoing advancements in transcatheter valve repair technology.

• Lucintel forecasts that, within the product type category, transcatheter aortic valve replacement is expected to witness the highest growth.
• Within the end-use category, hospitals are expected to witness the highest growth.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the presence of a well-established healthcare infrastructure in this region.

Gain Valuable Insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Transcatheter Valve Repair System Market

The transcatheter valve repair system market has various emerging trends; these include improvements in technology and changes in the way people approach their health. These trends are changing the paradigm and creating better and new gaps from which stakeholders will benefit.

• Minimally Invasive Procedures: Procedures that do not require an incision have been on the rise in recent years. These procedures also have quicker recovery times and fewer complications, which favor both patients and healthcare practitioners. As developments in technology occur, more conditions can be treated.
• Technological Innovations: Advancements in the design of devices, materials, and delivery systems have remained the growth drivers of the market. The developing trends include the use of biodegradable materials and improved imaging techniques, which contribute to speeding up compliance.
• Growing Clinical Evidence: The rising clinical evidence supporting the use and effectiveness of transcatheter valve repair systems is aiding market growth. With increasing positive outcomes in clinical studies, healthcare providers are more inclined to adopt such technologies in their practice.
• Regulatory Support: Supportive regulatory policies in several countries provide little resistance to new device approval, leading to speedy registration. It is essential that this pattern allows manufacturers to rapidly introduce new and innovative products into the market, thereby broadening the competitive landscape and providing greater diversity in treatment.
• Increased Focus on Patient Outcomes: The trend toward patient-oriented care is affecting practice in developing transcatheter valve systems. The development of devices that allow patients to remain in the hospital for a shorter duration and enhance the quality of life for patients is likely to influence product development direction among manufacturers.

These trends are significantly impacting the transcatheter valve repair system market by emphasizing innovations, patient safety, and regulatory aid. With regard to such trends in the management of heart valve disorders, the market is likely to adapt toward development and improved strategies for these patients.

Recent Developments in the Transcatheter Valve Repair System Market

Within the transcatheter valve repair system market, several significant events are taking place that define its growth strategies. Such developments are critical in improving treatment safety and widening the scope of treatment.

• New Device Approvals: The recently granted marketing authorizations for novel transcatheter devices, such as those by the FDA, are enhancing market optimism. Such approvals ease the entry of new devices and provide opportunities for better management techniques.
• Enhanced Delivery Systems: Other improvements in delivery systems, such as catheter designs and access techniques, are making procedures less risky and more efficient. These improvements reduce the risk of complications and increase the success rate of the procedures.
• Collaborative Research Initiatives: Research on transcatheter valve systems is being carried out as a result of collaboration between manufacturers and academic institutions. Joint endeavors help simplify device performance and broaden the clinical evidence regarding the application of the device.
• Focus on Workforce Education and Training: Increased attention to training healthcare personnel in transcatheter techniques is positively affecting uptake rates. Clinicians become skilled in these advanced techniques through training programs and workshops.

These developments are crucial as they enhance the transcatheter valve repair system market by improving device efficacy, increasing the scope of applications, and providing training. As long as these developments continue in succession, the market will be in a good position for future advancements and growth in cardiovascular treatment.

Strategic Growth Opportunities for Transcatheter Valve Repair System Market

The transcatheter valve repair system market offers numerous strategic growth opportunities across key applications. By focusing on these areas, stakeholders can enhance their market position and improve patient care.

• Expansion in Geriatric Care: The growing aging population presents opportunities to develop specialized transcatheter solutions tailored for elderly patients, who often face higher risks with traditional surgeries.
• Development of Customizable Devices: Creating customizable transcatheter devices that cater to individual anatomical variations can enhance procedural success rates and improve patient outcomes.
• Increasing Telemedicine Integration: Integrating telemedicine solutions for pre-and post-procedure care can streamline patient management and improve access to specialists, especially in rural areas.
• Focus on Clinical Trials: Investing in clinical trials for new applications of transcatheter valve repair systems can yield valuable data that supports regulatory approvals and enhances market acceptance.

These strategic growth opportunities are shaping the transcatheter valve repair system market by enhancing product offerings, improving patient access, and fostering innovation. Stakeholders who leverage these opportunities will likely strengthen their competitive position in the evolving healthcare landscape.

Transcatheter Valve Repair System Market Driver and Challenges

The transcatheter valve repair system market has interacted with dynamics in technology, the economy, and policy, which have acted as both enablers and hindrances. Knowledge of these factors is important for stakeholders who wish to participate in this rapidly transforming system.

The factors responsible for driving the transcatheter valve repair system market include:

1. Rising Incidence of Heart Disease: The ever-increasing rate of occurrence of heart diseases is propelling the demand for novel catheter-based procedures, providing ample room for growth in the market.

2. Technological Advancements: Improvements in device technology, including device constructs and device materials, continue to revolutionize transcatheter valve therapy and further entice clinicians.

3. Patient Preference for Minimally Invasive Procedures: Increasing patient knowledge and levels of seeking less invasive procedures are contributing positively to the market for transcatheter valve repair systems.

4. Supportive Regulatory Environment: Favorable regulatory policies in several nations enable faster timelines for the greenlighting of novel devices in the marketplace, helping to propel new ideas and sharpen competition in the space.

5. Increasing Investment in Cardiovascular Research: As more funds are put into cardiovascular studies, this will trigger the development of new transcatheter therapies that are currently in demand and will improve the standard of care.

Challenges in the transcatheter valve repair system market are:

1. High Cost of Procedures: The availability of transcatheter procedures has associated high costs that may prevent some patients from being treated; thus, disparities in care may be observed across different populations.

2. Regulatory Hurdles: There are positive elements of regulation as it stands; however, approval for new devices, especially new product development, can be complicated, leading to delays in introducing new products into the market.

3. Threat of Existing Surgical Methods: There are still a number of traditional treatments that are well established, and these challenge transcatheter solutions, requiring continual proof of their benefits.

The relationship between such drivers and challenges is critical in the transcatheter valve repair system market. With such diplomatic relations, stakeholders will make better products and provide quality patient care, which would assist in changing treatment practices for the better.

List of Transcatheter Valve Repair System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transcatheter valve repair system companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transcatheter valve repair system companies profiled in this report include-

• Abbott Laboratories
• Medtronic
• Boston Scientific
• Edwards Lifesciences
• Bracco Group
• LivaNova
• Meril Life Sciences
• Sorin Group
• Cordis
• MicroPort Scientific

Transcatheter Valve Repair System by Segment

The study includes a forecast for the global transcatheter valve repair system market by product type, application, end use, and region.

Transcatheter Valve Repair System Market by Product Type [Analysis by Value from 2019 to 2031]:

• Transcatheter Aortic Valve Replacement
• Transcatheter Mitral Valve Replacement
• Transcatheter Pulmonary Valve Replacement
• Transcatheter Tricuspid Valve Replacement

Transcatheter Valve Repair System Market by Application [Analysis by Value from 2019 to 2031]:

• Aortic Stenosis
• Mitral Stenosis
• Tricuspid Stenosis
• Pulmonary Stenosis

Transcatheter Valve Repair System Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

Transcatheter Valve Repair System Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Transcatheter Valve Repair System Market

The transcatheter valve repair system market is changing quickly due to technological development and a rise in patient preference for less invasive procedures. This growth is attributed mainly to places such as the United States, China, Germany, India, and Japan, where heads of health systems are directing fresh approaches to heart valve diseases, thus enhancing outcomes and access to patients.

• United States: The U.S. market is currently undergoing rapid developments in transcatheter mitral valve repair systems, with new devices recently gaining FDA approval. Companies are investing in trials aimed at evaluating the long-term effectiveness and safety of the devices. Moreover, the growing burden of heart diseases is creating a need for less invasive techniques and therefore supporting market growth.
• China: In China, the transcatheter valve repair system market is also growing quickly because health consciousness and acceptance of advanced cardiac treatments have increased. The government's recent efforts to improve cardiovascular healthcare infrastructure are working to ensure that these technologies are adopted more quickly. Domestic companies are joining partnerships with overseas companies to improve products and increase market share.
• Germany: As one of the prominent countries in the field of research and development of transcatheter devices, Germany has the largest European market share in transcatheter valve repair systems. As a result of many clinical studies reporting positive outcomes with various transcatheter devices, these approaches have been embraced where possible. Moreover, the country's healthcare system is favorable for the introduction of new technologies in the field of practice.
• India: In India, the market for transcatheter valve repair systems is growing due to better healthcare coverage and the increasing burden of heart ailments. Domestic manufacturers are developing reasonably priced products for the Indian market. Initiatives taken by the government to upgrade cardiac care systems and partnerships with international players are also helping in market growth.
• Japan: The market in Japan has stringent regulatory requirements and places implicit reliance on regulatory quality. Market growth is on the rise due to recent approvals of new advanced transcatheter valve systems. In addition, the increasing elderly population and the rise in the prevalence of cardiovascular diseases are driving demand for effective and safe non-surgical approaches for treatment.

Features of the Global Transcatheter Valve Repair System Market

Market Size Estimates: Transcatheter valve repair system market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Transcatheter valve repair system market size by product type, application, end use, and region in terms of value ($B).

Regional Analysis: Transcatheter valve repair system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, end uses, and regions for the transcatheter valve repair system market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transcatheter valve repair system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the transcatheter valve repair system market by product type (transcatheter aortic valve replacement, transcatheter mitral valve replacement, transcatheter pulmonary valve replacement, and transcatheter tricuspid valve replacement), application (aortic stenosis, mitral stenosis, tricuspid stenosis, and pulmonary stenosis), end use (hospitals, specialty clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transcatheter Valve Repair System Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Transcatheter Valve Repair System Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Transcatheter Valve Repair System Market by Product Type
  • 3.3.1: Transcatheter Aortic Valve Replacement
  • 3.3.2: Transcatheter Mitral Valve Replacement
  • 3.3.3: Transcatheter Pulmonary Valve Replacement
  • 3.3.4: Transcatheter Tricuspid Valve Replacement
• 3.4: Global Transcatheter Valve Repair System Market by Application
  • 3.4.1: Aortic Stenosis
  • 3.4.2: Mitral Stenosis
  • 3.4.3: Tricuspid Stenosis
  • 3.4.4: Pulmonary Stenosis
• 3.5: Global Transcatheter Valve Repair System Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Specialty Clinics
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Transcatheter Valve Repair System Market by Region
• 4.2: North American Transcatheter Valve Repair System Market
  • 4.2.1: North American Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
  • 4.2.2: North American Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Transcatheter Valve Repair System Market
  • 4.3.1: European Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
  • 4.3.2: European Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Transcatheter Valve Repair System Market
  • 4.4.1: APAC Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
  • 4.4.2: APAC Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Transcatheter Valve Repair System Market
  • 4.5.1: ROW Market by Product Type: Transcatheter Aortic Valve Replacement, Transcatheter Mitral Valve Replacement, Transcatheter Pulmonary Valve Replacement, and Transcatheter Tricuspid Valve Replacement
  • 4.5.2: ROW Market by End Use: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Transcatheter Valve Repair System Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Transcatheter Valve Repair System Market by Application
  • 6.1.3: Growth Opportunities for the Global Transcatheter Valve Repair System Market by End Use
  • 6.1.4: Growth Opportunities for the Global Transcatheter Valve Repair System Market by Region
• 6.2: Emerging Trends in the Global Transcatheter Valve Repair System Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Transcatheter Valve Repair System Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transcatheter Valve Repair System Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Medtronic
• 7.3: Boston Scientific
• 7.4: Edwards Lifesciences
• 7.5: Bracco Group
• 7.6: LivaNova
• 7.7: Meril Life Sciences
• 7.8: Sorin Group
• 7.9: Cordis
• 7.10: MicroPort Scientific